- Home
- PAR vs SLNO Comparison
PAR vs SLNO Comparison
Compare PAR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- SLNO
- Stock Information
- Founded
- PAR 1968
- SLNO 1999
- Country
- PAR United States
- SLNO United States
- Employees
- PAR N/A
- SLNO N/A
- Industry
- PAR Office Equipment/Supplies/Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PAR Miscellaneous
- SLNO Health Care
- Exchange
- PAR Nasdaq
- SLNO Nasdaq
- Market Cap
- PAR 2.8B
- SLNO 3.2B
- IPO Year
- PAR N/A
- SLNO 2014
- Fundamental
- Price
- PAR $65.60
- SLNO $73.35
- Analyst Decision
- PAR Strong Buy
- SLNO Strong Buy
- Analyst Count
- PAR 7
- SLNO 9
- Target Price
- PAR $79.86
- SLNO $103.33
- AVG Volume (30 Days)
- PAR 441.6K
- SLNO 744.8K
- Earning Date
- PAR 05-09-2025
- SLNO 05-07-2025
- Dividend Yield
- PAR N/A
- SLNO N/A
- EPS Growth
- PAR N/A
- SLNO N/A
- EPS
- PAR N/A
- SLNO N/A
- Revenue
- PAR $383,768,000.00
- SLNO N/A
- Revenue This Year
- PAR $30.49
- SLNO N/A
- Revenue Next Year
- PAR $16.19
- SLNO N/A
- P/E Ratio
- PAR N/A
- SLNO N/A
- Revenue Growth
- PAR 37.95
- SLNO N/A
- 52 Week Low
- PAR $41.86
- SLNO $36.93
- 52 Week High
- PAR $82.24
- SLNO $80.99
- Technical
- Relative Strength Index (RSI)
- PAR 53.70
- SLNO 49.78
- Support Level
- PAR $65.04
- SLNO $72.29
- Resistance Level
- PAR $68.29
- SLNO $78.32
- Average True Range (ATR)
- PAR 2.10
- SLNO 2.74
- MACD
- PAR -0.44
- SLNO -0.57
- Stochastic Oscillator
- PAR 20.77
- SLNO 27.11
About PAR PAR Technology Corporation
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.